Articles with public access mandates - GS WuLearn more
Not available anywhere: 1
Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells
JM Pimentel, JY Zhou, GS Wu
Molecular Carcinogenesis 62 (2), 135-144, 2023
Mandates: US National Institutes of Health
Available somewhere: 35
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Mandates: Swiss National Science Foundation, US National Institutes of Health, US …
Notch signaling: an emerging therapeutic target for cancer treatment
X Yuan, H Wu, H Xu, H Xiong, Q Chu, S Yu, GS Wu, K Wu
Cancer letters 369 (1), 20-27, 2015
Mandates: National Natural Science Foundation of China
Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects
JE Allen, G Krigsfeld, PA Mayes, L Patel, DT Dicker, AS Patel, NG Dolloff, ...
Science translational medicine 5 (171), 171ra17-171ra17, 2013
Mandates: US National Institutes of Health
Role of autophagy in cisplatin resistance in ovarian cancer cells
J Wang, GS Wu
Journal of Biological chemistry 289 (24), 17163-17173, 2014
Mandates: US National Institutes of Health
Developing TRAIL/TRAIL death receptor-based cancer therapies
X Yuan, A Gajan, Q Chu, H Xiong, K Wu, GS Wu
Cancer and Metastasis Reviews 37, 733-748, 2018
Mandates: US National Institutes of Health, National Natural Science Foundation of China
Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells
DJ Peng, J Wang, JY Zhou, GS Wu
Biochemical and biophysical research communications 394 (3), 600-605, 2010
Mandates: US National Institutes of Health
Discovery and clinical introduction of first-in-class imipridone ONC201
JE Allen, CLB Kline, VV Prabhu, J Wagner, J Ishizawa, N Madhukar, ...
Oncotarget 7 (45), 74380, 2016
Mandates: US National Institutes of Health
The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment
KK Haagenson, GS Wu
Cancer and Metastasis Reviews 29, 143-149, 2010
Mandates: US National Institutes of Health
Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells
J Xu, JY Zhou, WZ Wei, GS Wu
PloS one 5 (4), e10226, 2010
Mandates: US National Institutes of Health
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway
JE Allen, G Krigsfeld, L Patel, PA Mayes, DT Dicker, GS Wu, WS El-Deiry
Molecular cancer 14, 1-10, 2015
Mandates: US National Institutes of Health
Mitogen activated protein kinase phosphatases and cancer
KK Haagenson, GS Wu
Cancer biology & therapy 9 (5), 337-340, 2010
Mandates: US National Institutes of Health
MCL-1 dependency of cisplatin-resistant cancer cells
J Michels, F Obrist, I Vitale, D Lissa, P Garcia, P Behnam-Motlagh, ...
Biochemical pharmacology 92 (1), 55-61, 2014
Mandates: European Commission, Swiss Cancer League
CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
H Xu, K Wu, Y Tian, Q Liu, N Han, X Yuan, L Zhang, GS Wu, K Wu
International journal of oncology 49 (4), 1343-1350, 2016
Mandates: National Natural Science Foundation of China
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study
V Balan, P Nangia-Makker, AG Schwartz, YS Jung, L Tait, V Hogan, T Raz, ...
Cancer research 68 (24), 10045-10050, 2008
Mandates: US National Institutes of Health
Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells
J Wang, JY Zhou, L Zhang, GS Wu
Cell Cycle 8 (19), 3191-3198, 2009
Mandates: US National Institutes of Health
Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy
J Wang, JY Zhou, D Kho, JJ Reiners Jr, GS Wu
Autophagy 12 (10), 1791-1803, 2016
Mandates: US National Institutes of Health
Sp1-mediated TRAIL induction in chemosensitization
J Xu, JY Zhou, WZ Wei, S Philipsen, GS Wu
Cancer research 68 (16), 6718-6726, 2008
Mandates: US National Institutes of Health
Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERK
P Dong, JY Zhou, GS Wu
Cell cycle 9 (23), 4650-4655, 2010
Mandates: US National Institutes of Health
Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis
HX Xu, KJ Wu, YJ Tian, Q Liu, N Han, XL He, X Yuan, GS Wu, KM Wu
Medicine 95 (27), e4085, 2016
Mandates: National Natural Science Foundation of China
Publication and funding information is determined automatically by a computer program